Table 2
Treatment data
| Pretreatment examination | Most recent examination | ||||||
|---|---|---|---|---|---|---|---|
| Patient No | Visual acuity‡ | Visual field loss | Progression in imaging | Visual acuity‡ ‡‡ | Visual field loss‡‡ | Follow up after treatment (months) | Outcome |
| *l = left; r = right; b = bilateral. | |||||||
| †Location: 1 = orbital; 2 = orbital and optic nerve canal; 3 = orbit, optic nerve canal, and intracranial extension; 4 = canalicular. | |||||||
| ‡NLP = no light perception; LP = light perception; FC = finger counting. | |||||||
| §Low visual acuity due to inadequate spectacle correction. | |||||||
| ∥Patient No 2 is suffering from bilateral ONSM, therefore mentioned twice. | |||||||
| ¶Additional systemic steroidtherapy. | |||||||
| **Biopsy. | |||||||
| ††Low visual acuity due to amblyopia. | |||||||
| ‡‡Bold figures denote amelioration. | |||||||
| 1 | 0.6§ | 72% | − | 1.0 | 4% | 43 | Improved |
| 2∥¶ | 1.0 | 72% | − | 1.2 | 4% | Improved | |
| 3 | 1.0 | 92% | − | 1.0 | 78% | 46 | Improved |
| 4 | 1.2 | 68% | + | 1.0 | 40% | 16 | Improved |
| 5¶ | 0.8 | 58% | − | 0.6 | 49% | 49 | Improved |
| 6¶** | 0.4 | 81% | + | 0.4 | 73% | 21 | Improved |
| 7¶** | FC | 84% | − | 0.1 | NK | 37 | Improved |
| 8 | 1.0 | 0% | + | 0.8 | 6% | 12 | Stable |
| 9 | 0.32†† | 66% | + | 0.2 | 64% | 22 | Stable |
| 10 | 0.63 | 68% | − | 0.8 | 72% | 45 | Stable |
| 11¶ | 1.25 | 2% | − | 1.2 | 2% | 32 | Stable |
| 12** | 0.8 | 2% | + | 0.8 | NK | 23 | Stable |
| 13 | LP | 100% | + | LP | 100% | 15 | Stable/blind |
| 14 | LP | 100% | − | NLP | 100% | 43 | Stable/blind |
| 15¶ | NLP | 100% | − | NLP | 100% | 71 | Stable/blind |
| 2∥¶ | LP | 100% | − | NLP | 100% | 38 | Stable/blind |
